Look here then:
https://www.cmaj.ca/content/193/42/E1619
Increased risk [compared to non-variant-of-concern SARS-COV-2] with the Delta variant was more pronounced at 108% (95% CI 78%–140%) for hospitalization, 235% (95% CI 160%–331%) for ICU admission and 133% (95% CI 54%–231%) for death.
Compared with non-VOC SARS-CoV-2 strains, the adjusted elevation in risk associated with N501Y-positive variants was 52% (95% confidence interval [CI] 42%–63%) for hospitalization, 89% (95% CI 67%–117%) for ICU admission and 51% (95% CI 30%–78%) for death.
N501Y is alpha
Immunity is always the goal if you can get it. It's not how you judge success though, you're right.
Thankfully the vaccines do drastically reduce severe illnesses though, so that's something.